FUNCTIONAL STATE OF VASCULAR ENDOTHELIUM IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH CONGENITAL HEART DISEASES

被引:0
|
作者
Emeryanchik, E. Yu [1 ]
Vol'f, N. G. [2 ]
Vesemiller, O. A. [1 ]
Salmina, A. B. [1 ]
机构
[1] Krasnoyarsk State Med Univ, Krasnoyarsk, Russia
[2] Krasnoyarsk Reg Clin Ctr Matern & Childhood Prote, Krasnoyarsk, Russia
关键词
pulmonary arterial hypertension; congenital heart disease; endothelial dysfunction; vascular endothelial growth factor; membrane blebbing; peripheral blood lymphocytes; soluble platelet/endothelial cell adhesion molecule 1; hypoxia; apoptosis; CELLS; MICROPARTICLES;
D O I
10.18087/cardio.2017.8.10016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this article, we present results of the study of blebbing activity of membranes of peripheral blood lymphocytes, concentrations of soluble platelet/endothelial cell adhesion molecule 1, and vascular endothelial growth factor (VEGF) in patients with pulmonary arterial hypertension associated with congenital heart diseases. The research has shown that hypoxia and hemodynamic factors are the initiators of blebbing of membrane of peripheral blood lymphocytes. The activity of blebbing increases in parallel with the severity of the disease. Aberrant leukocyte-endothelial interactions lead to the breach of athrombogenic endothelium function, hypercoagulation and risk of thrombosis. Revealed overexpression of VEGF, aimed at restoration of endothelial cells, has been most pronounced in cyanotic congenital heart defects. We suggest that the potentiating effect of apoptosis and endothelial cells' proliferation is a key factor of irreversibility of pulmonary arterial hypertension in congenital heart defects.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [41] Changing demographics of pulmonary arterial hypertension in congenital heart disease
    Mulder, B. J. M.
    EUROPEAN RESPIRATORY REVIEW, 2010, 19 (118) : 308 - 313
  • [42] How to evaluate patients with congenital heart disease-related pulmonary arterial hypertension
    Ntiloudi, Despoina
    Zanos, Stavros
    Gatzoulis, Michael A.
    Karvounis, Haralambos
    Giannakoulas, George
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (01) : 11 - 18
  • [43] Accuracy of Doppler echocardiography in the assessment of pulmonary arterial hypertension in patients with congenital heart disease
    Wang, B.
    Feng, Y.
    Jia, L-Q
    Wu, X-L
    Li, D-D
    Zhou, H-X
    Yang, J.
    Liang, B-M
    Wang, L.
    Cui, K-J
    Huang, H.
    Yi, Q.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (07) : 923 - 928
  • [44] Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension
    Li, Xiao-ye
    Zheng, Yu
    Long, Yuliang
    Zhang, Xiaochun
    Zhang, Lei
    Tian, Dan
    Zhou, Daxin
    Lv, Qian-zhou
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (09): : 914 - 923
  • [45] Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults
    Liu, Wenshi
    Hua, Ying
    Zheng, Dongdong
    Lv, Wenjing
    Zhang, Wei
    Chen, Qianqian
    Huang, Rong
    Li, Xiaofei
    CIRCULATION JOURNAL, 2023, 87 (04) : 527 - +
  • [46] Pulmonary arterial hypertension: closing the gap in congenital heart disease
    Brida, Margarita
    Nashat, Heba
    Gatzoulis, Michael A.
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 422 - 428
  • [47] Use of the index of pulmonary vascular disease for predicting longterm outcome of pulmonary arterial hypertension associated with congenital heart disease (vol 10, 1212882, 2023)
    Chida-Nagai, Ayako
    Masaki, Naoki
    Maeda, Kay
    Sasaki, Konosuke
    Sato, Hiroki
    Muneuchi, Jun
    Ochiai, Yoshie
    Murayama, Hiroomi
    Tahara, Masahiro
    Shiono, Atsuko
    Shinozuka, Atsushi
    Kono, Fumihiko
    Machida, Daisuke
    Toyooka, Shinichi
    Sugimoto, Seiichiro
    Nakamura, Kazufumi
    Akagi, Satoshi
    Kondo, Maiko
    Kasahara, Shingo
    Kotani, Yasuhiro
    Koizumi, Junichi
    Oda, Katsuhiko
    Harada, Masako
    Nakajima, Daisuke
    Murata, Akira
    Nagata, Hazumu
    Yatsunami, Koichi
    Kobayashi, Tomio
    Matsunaga, Yoshikiyo
    Inoue, Takahiro
    Yamagishi, Hiroyuki
    Nakagawa, Naomi
    Ohtani, Katsuki
    Yamamoto, Masaki
    Ito, Yushi
    Hokosaki, Tatsunori
    Kuwahara, Yuta
    Masutani, Satoshi
    Nomura, Koji
    Wada, Tsutomu
    Sawada, Hirofumi
    Abiko, Masayuki
    Takahashi, Tatsunori
    Ishikawa, Yuichi
    Okada, Seigo
    Naitoh, Atsushi
    Toda, Takako
    Ando, Tatsuya
    Masuzawa, Akihiro
    Hoshino, Shinsuke
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [48] The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease
    Zeng, Haowei
    Lan, Beidi
    Li, Bingyi
    Xie, Hang
    Zhao, Enfa
    Liu, Xiaoqin
    Xue, Xiaoyi
    Sun, Jingyan
    Su, Linjie
    Zhang, Yushun
    RESPIRATORY RESEARCH, 2024, 25 (01)
  • [49] Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
    Yaylali, Yalin Tolga
    Yagmur, Burcu
    Sinan, Umit Yasar
    Meric, Murat
    Basarici, Ibrahim
    Avci, Burcak Kilickiran
    Senol, Hande
    Nalbantgil, Sanem
    Kucukoglu, Serdar
    Ongen, Zeki
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (08) : 479 - 485
  • [50] Risk Stratification fi cation and Prognosis of Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Dong, Wenjie
    Hong, Zhibin
    Wang, Aqian
    Jiang, Kaiyu
    Zhu, Hai
    Zhang, Fu
    Guo, Zhaoxia
    Su, Hongling
    Cao, Yunshan
    CONGENITAL HEART DISEASE, 2024, 19 (03) : 325 - 339